Metformin is the currently recommended first-line treatment of T2DM and exerts its effects by inhibiting hepatic gluconeogenesis and increasing insulin sensitivity, resulting in enhanced glucose uptake and reduced blood glucose levels [72,73]. This evidence concerns the gene INS and type 2 diabetes mellitus.